[ Home ] [ Up ] [ Search ] [ Feedback ] [ Contact Us ]
   

Dr. William H. Jennings, MD, FACP

  
 

Dr. Jennings is a native of Hutchinson, and has lifelong family ties to the Pratt area. He is a graduate of the University of Kansas School of Medicine, and completed an Internal Medicine residency and Hematology fellowship at the Mayo Clinic. Dr. Jennings is certified by the American Board of Internal Medicine and the subspecialty Boards in Hematology and Medical Oncology. His additional areas of professional interest include bleeding and clotting disorders, medical ethics, and palliative care

Dr. Jennings was in the private practice of Hematology and Oncology in Greeley, Colorado from 1976 to 1988. Since 1988, he has been a member of the faculty at the University of Missouri-Kansas City School of Medicine, and is an Associate Professor in the Department of Internal Medicine.

 

In addition to his teaching responsibilities, he is co-director of the Mid-west Hemophilia Center in Kansas City, and Chairman of the Ethics Committee at Truman Medical Center. He has been in practice at Pratt Regional Medical Center since 1997 and joined the Cancer Center of Kansas group in 2002. He is a member of the American College of Physicians, The American Society of Hematology, The American Society of Clinical Oncology, and The International Society of Hematology.

 

 
Dr. Jennings' Complete Cirruculum Vita (Word Format)  

CURRICULUM VITAE

Name: William H. Jennings, M.D., FACP

Date of Birth: November 25, 1941

Place of Birth: Hutchinson, Kansas, USA


Address (Office): University of Missouri-Kansas City School of Medicine
2411 Holmes
Kansas City, MO 64108-2792
Ph: (816) 235-1924
Fax: (816) 235-5538)

Internet Address: Jenningsw@umkc.edu

EDUCATION:
1968 M.D., University of Kansas
Medical School
Kansas City, KS

1964 Pre-Med Education
University of Oregon
Eugene, Oregon

1963 B.A. (Economics), Carleton College
Northfield, Minnesota

POST-GRADUATE TRAINING:
1974-1976 Fellowship, Hematology
Mayo Graduate School of Medicine
Rochester, Minnesota

1972-1974 Residency, Internal Medicine
Mayo Graduate School of Medicine
Rochester, Minnesota


1968-1969 Internship
University of New Mexico
Albuquerque, New Mexico

MILITARY SERVICE:
1969-1971 U.S. Public Health Service
Zuni, New Mexico (Lt. CMDR.)

1971-1972 U.S. Public Health Service
Boston, Massachusetts

LICENSURE: Colorado State Board of Medicine #20193
Minnesota State Board of Medical Examiners #20121
Missouri State Board of Registration for the Healing Arts #31969
Kansas State Board of Medical Examiners #27061

BOARD CERTIFICATION:
06/10/75
10/19/76
11/07/89 Diplomate, American Board of Internal Medicine
Diplomate, Subspecialty of Hematology (ABIM)
Diplomate, Subspecialty of Medical Oncology (ABIM)

ACADEMIC POSITIONS:
1975-1976 Instructor, Mayo Medical School
1976-1988 Clinical Faculty – Family Practice
Residency – North Colorado Medical Center
1988-present Associate Professor – Dept. of Internal Medicine, University of Missouri – Kansas City School of Medicine
1998-2000 Interim Vice Chairman of Internal Medicine – Department of Internal Medicine, University of Missouri – Kansas City School of Medicine and Truman Medical Center

STAFF MEMBERSHIPS: Hematology, Medical Oncology
1976-1988 Greeley Medical Clinic and North Colorado Medical Center, Greeley, CO
1977-1980 Poudre Valley Memorial Hospital, Fort Collins, CO.
1979-1988 McKee Medical Center, Loveland, CO
1988-present Truman Medical Center, Kansas City, MO
1992-2000 St. Luke’s Hospital, Kansas City, MO
1997-present Pratt Regional Medical Center, Pratt, KS


PRACTICE RELATED ACTIVITIES:
1977 Development of an Oncology Nursing Unit – North Colorado Medical Center
1977-1988 Medical Director – Hospice of Weld County
1980-1988 Continuing Cancer Education
Series for Hospital Staff – North Colorado Medical Center
1981-1988 Regular participation in patient support groups including “I Can Cope,” Cansurmount education, “Cansupport,” and “Care and Share”
1985-1987 Chairman, Cancer Committee – North Colorado Med Center
1988-Present Member, Oncology Committee – Truman Medical Center, Kansas City, MO
1988-1994 Director, Adult Sickle Cell Treatment Program – Truman Medical Center, Kansas City, MO
1989-Present Co-director, Midwest Comprehensive Hemophilia Center, Kansas City, MO
1991-2000 Assistant Program Director, Internal Medicine Residency, Truman Medical Center, Kansas City, MO
1994-1997 Co-director, Hemostasis and Thrombosis Laboratory, UMKC School of Medicine, Kansas City, MO
1994-Present Member, Ethics Committee, Truman Medical Center, Kansas City, MO. Chairman, 1997-Present
1995-Present Bi-monthly Case Conference Presentation, Oncology/HIV Nursing Unit, Truman Medical Center, Kansas City, MO
1997 Physicians Management and Education Course (Mini-MBA for Physicians). UMKC – Henry W. Bloch School of Business and Public Administration. September through December, 1997

SOCIETY MEMBERSHIPS: American College of Physicians (Fellow)
American Society of Hematology
American Society of Clinical Oncology
International Society of Hematology
Metropolitan Medical Society of Greater Kansas City
Kansas Medical Society


EDUCATION – TEACHING:
Docent – UMKC School of Medicine (Gold Unit)
This role is one of teacher and advisor to medical students which provides continuity and ongoing mentorship for these students through the last four years of medical school. The docent supervises a group of twelve students, consisting of three students each in years three through six of the UMKC School of Medicine six-year program. The docent is with the students weekly in an Internal Medicine continuity clinic, and for two months per year on an inpatient internal medicine hospital service. In addition, the docent’s role in conjunction with the educational assistant requires at a minimum quarterly reassessment of the student’s progress, individual student supervision and curriculum management.

Courses Taught:
Clinical one-month elective in Hematology/Medical Oncology (one to two students per month in years four-six). Three to four months per year, 1988 to present. Course #340R, 341R

Docent Rotation (two-month inpatient Internal Medicine Rotation) – Twelve students per rotation, 1988 to 2000. Course #301R, 302R, 401R, 402R, 501R, 502R, 601R, 602R.

Internal Medicine Clinic (two sessions per week, approximately eight students per session, years three-six), 1988 to 2000. Course #303R, 403R, 503R, 603R

Directed Study in Internal Medicine I. One to two students for one month per year, 1988 to 1997. Course #327R

Human BioChemistry I (one lecture on Sickle Cell Anemia), 9/96, 9/97, 9/98, 9/99. (Approximately 100 students per course). Course #BMS365.

Human BioChemistry II (one lecture on Porphyria), 3/00 (approximately 100 students per course). Course # BMS368.

Current Lectures:
1. Anemia – evaluation and diagnosis
2. Monoclonal Gammopathies
3. Myelodysplastic Syndromes
4. Acute Leukemia
5. Chronic Lymphocytic Leukemia
6. Myeloproliferative Disorders
7. Small Cell Lung Cancer – Treatment
8. Non-Small Cell Lung Cancer – classification and treatment
9. Colon Cancer – diagnosis and treatment
10. Breast Cancer Screening/Hereditary Issues
11. Evaluation of a prolonged PT or APTT
12. Thrombophilia – evaluation and workup
13. Lupus Anti-coagulants
14. Breast Cancer – adjuvant treatment
15. Advanced Breast Cancer Treatment
16. Prostate Cancer
17. Hodgkin’s Disease – staging and treatment
18. Non-Hodgkin’s Lymphoma – classification and treatment
19. Thrombocytopenia – evaluation and diagnosis
20. Pancytopenia – evaluation
21. Hematologic Effects of Alcohol
22. Hematologic Effects of HIV
23. Pain Management
24. Hospital Ethics Committee – form and function
25. Pharmacology of Cancer Chemotherapy
Graduate Work Supervision:
Internal Medicine Residency: Supervision and Instruction of Internal Medicine residents while on docent rotation, Hematology/Medical Oncology inpatient Electives, Hematology/Medical Oncology Clinic (approximately forty internal medicine residents per year), 1988 to present.
Assistant Program Director, Internal Medicine Residency, 1991 to present.
Hematology/Oncology Fellowship: Supervision of Clinical and Research Training of Subspecialty Fellows as a member of the section of Hematology/Medical Oncology, 1988 to present.

Miscellaneous Lectures and Conferences:
UMKC School of Medicine/Truman Medical Center – thirty noon conferences (approximately 60 medical students, residents, fellows and physicians in attendance), 1988 to present.
Weekly tumor conference participation (approximately 25 medical students, residents, fellows, physicians and staff per conference), 1988 to present.
Moderator of a monthly medical ethics case discussion at internal medicine morning report, Truman Medical Center (1997 to present). This is a discussion of a recent hospitalized patient who presents an ethical question and who has been seen in ethics consultation. This conference is presented to medical students, residents, fellows, and physicians. (40 per session)


PUBLICATIONS/ABSTRACTS:
Jennings, W.H., Li, C.Y., Kiely, J.M.. – Concomitant Myelofibrosis with Agnogenic Myeloid Metaplasia and Malignant Lymphoma. Mayo Clinic Proc. 1983, 58. 617-619.
Jennings, W.H., Kiely, J.M., Li, C.Y., White, W. – Primary Retroperitoneal Lymphoma. Poster Session, XXI Congress of the International Society of Hematology, Sidney, Australia, May 1986.
Jennings, W.H., Zachary, P., Stanford, J.F. – Polymicrobial Anaerobic Osteomyelitis. A Case Report with Analysis of the Adjunctive Role of Anaerobic Susceptibility Testing. Abstract. Sixteenth Annual Meeting of the National Sickle Cell Disease Program. Mobile, Alabama. March 24-26, 1991.
Raible, M.D., Massey, V., DePond, W., Jennings, W.H. – Extraosseous Osteosarcoma of the Neck. Submitted to the Journal of Otolaryngology. April, 1998.
Jennings, W.H.: Book Review – Ethics Case Book for Hospitals; Practical Approaches to Everyday Cases, M.G. Kuczewski and R.L. Pinkus, eds. Bio Ethics Forum. 1999; 15(2):46.

INVITED PRESENTATIONS:
Advances in Sickle Cell Treatment. Fifth Annual Sickle Cell Conference, Kansas City Coalition for Sickle Cell Services. Kansas City, Missouri. September 22, 1989.
Tumor Biology. Cancer Management Course, American College of Surgeons. Estes Park, Colorado. August 10, 1990.
Carcinoma of Unknown Primary. Cancer Management Course, American College of Surgeons. Estes Park, Colorado. August 10, 1990.
Advances in Cancer Treatment. Block Cancer Management Center. Kansas City, Missouri. August 27, 1990.
Genetics of Sickle Cell Disease. Sixth Annual Sickle Cell Conference, Kansas City Coalition for Sickle Cell Services. Kansas City, Missouri. September 14, 1990.
Breast Cancer-Routine Follow-up and Evaluation. Menorah Medical Center. Kansas City, Missouri. September 11, 1990.
Advances in the Treatment of Prostate Cancer. Block Cancer Management Center. Kansas City, Missouri. December 11, 1990, April 15, 1992, and April 12, 1995.
Keynote Speaker. Cancer Survivor’s Day, McKee Wellness Center. Loveland, Colorado. June 7, 1992.
Factor IX Product Replacement. National Hemophilia Foundation Region V Annual Meeting. Kansas City, Missouri. June 11, 1993.
Coagulation Review and Hemastasis Cases, Welker Lecture. Trinity Lutheran Hospital, Kansas City, Missouri. April 6, 1994.
Hypercoagulability – Testing and Diagnosis. 1995 Missouri ACP-MSIM Combined Regional Meeting. Lake Ozark, Missouri. September 29, 1995.
The Development of a Hospital Based Ethics Committee. Truman Medical Center Ethics Seminar, Kansas City, Missouri. February 25, 1997.
Disorders of Platelets, Coagulation, and Thrombophilia. Internal Medicine Board Review Counse. University of Kansas Medical Center, Kansas City, Kansas. July 30, 1998.
Care of the Oncology Patient. Nursing Seminar Truman Medical Center, Kansas City, Missouri. August 28, 1998.
Pain Management, Palliative Care, and Ethical Issues. Nursing Seminar, Truman Medical Center, Kansas City, Missouri. August 29, 1998.
Hypercoagulable States – Laboratory Evaluation Monthly Medical Staff Conference. Pratt Regional Medical Center, Pratt, Kansas. February 5, 1999.
Disorders of Platelets, Coagulation, and Thrombophilia. Internal Medicine Board Review Course. University of Kansas Medical Center, Kansas City, Kansas. July 26, 1999 and July 17, 2000.
Prostate Cancer. Internal Medicine Board Review Course, University of Kansas Medical Center, Kansas City, Kansas. July 26, 1999 and July 17, 2000.
Oncology – A 25-Year Perspective. UMKC School of Medicine, Mini-Medical School Series. April 10, 2001.

Factor 5 Inhibitors. 61st International Meeting of the Mayo Alumni Association, Atlanta, Georgia. April 21, 2001.
Essentials in End-of-Life Care. Pratt Regional Medical Center, Pratt, Kansas. October 12-13, 2001.

GRANTS:
Prothrombin Fragment F1 + 2 Following Cerebral Thrombosis
Potential application in Anti-Thrombosis Management
Sarah Morrison Fund: 2,200.00, 1993.

Kansas City Regional Hemophilia Center
(Co-Director)
MCHB/CDC Funding for FY 2000-2001: $131,000.00